3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 31.20
-0.10 (-0.32%)
Sep 8, 2026, 1:57 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.07 billion as of September 8, 2026. Its market cap has decreased by -21.34% in one year.
Market Cap
3.07B
Enterprise Value
2.62B
Revenue
159.19M
Ranking
n/a
PE Ratio
216.78
Stock Price
31.20
ChartMarket Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.07B, an increase of 12.11%. That is a compound annual growth rate of 2.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 2.41B | -35.91% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 3.01B |
| Intech Biopharm | 2.97B |
| Chunghwa Chemical Synthesis & Biotech | 2.75B |
| Energenesis Biomedical CO.,LTD. | 2.68B |
| GlycoNex Incorporation | 2.49B |
| Anti-Microbial Savior BioteQ | 2.28B |
| HeXun Biosciences | 2.18B |
| Sunhawk Vision Biotech | 2.14B |